Cargando…
SUN-562 Hurthle Cell Carcinoma Presenting as Hyperfunctioning Nodule
Background: Hurthle cell carcinoma (HCC) is a rare type of aggressive follicular carcinoma comprising a small percentage of all thyroid cancers. It is associated with high metastasis and mortality rates with 20-30% of this type of cancer having metastatic extension at the time of treatment. HCC may...
Autores principales: | Aviles, Ednalyn, Capellan, Maria Leonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553411/ http://dx.doi.org/10.1210/js.2019-SUN-562 |
Ejemplares similares
-
SUN-615 Hurdles in Hurthle Cell Cancer: A Case Report on Hurthle Cell Thyroid Cancer with Vertebral Metastasis
por: Viar, John Ryan, et al.
Publicado: (2019) -
SUN-LB78 Hyperfunctioning Papillary Thyroid Carcinoma With a BRAF Mutation
por: Shinkai, Shinsuke, et al.
Publicado: (2020) -
SUN-478 Poorly Differentiated Thyroid Cancer Arising from a Hyperfunctioning Nodule Treated with I-131
por: Miller, Eli, et al.
Publicado: (2020) -
SAT562 Metastatic Oncocytic (Formerly Hürthle Cell) Thyroid Carcinoma in a Patient With Birt-Hogg-Dubé Syndrome
por: Vaid, Sonal, et al.
Publicado: (2023) -
PSAT296 Graves’ Disease and Hurthle Cell Carcinoma: A Rare Presentation
por: Bhatt, Plukshi J, et al.
Publicado: (2022)